Safety and Effectiveness of Magnetic Peripheral Nerve Stimulation for the Treatment of Chemotherapy Induced Neuropathy

NCT05935956 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 14

Last updated 2024-07-11

No results posted yet for this study

Summary

Assess the safety and effectiveness of Axon Therapy in the treatment of chemotherapy-induced neuropathy

Conditions

  • Neuralgia
  • Neuropathic Pain
  • Chemotherapy-induced Peripheral Neuropathy

Interventions

DEVICE

Magnetic Peripheral Nerve Stimulation

Magnetic Peripheral Nerve Stimulation

Sponsors & Collaborators

  • NeuraLace Medical, Inc.

    lead INDUSTRY

Principal Investigators

  • Carrie Johnson, MD, PhD · Carolinas Pain Institute and Center for Clinical Research

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-06-09
Primary Completion
2023-12-21
Completion
2023-12-21
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05935956 on ClinicalTrials.gov